Covea Finance Dexcom Inc Transaction History

Covea Finance

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$59.83 - $87.57 $1.63 Million - $2.39 Million	27,300 Added 32.54%	111,200 $9.71 Million
Q1 2025 Apr 22, 2025	SELL	$67.74 - $90.75 $10 Million - $13.4 Million	-147,910 Reduced 63.81%	83,900 $5.73 Million
Q3 2024 Oct 10, 2024	SELL	$64.0 - $116.06 $1.39 Million - $2.52 Million	-21,700 Reduced 8.56%	231,810 $15.5 Million
Q2 2024 Jul 16, 2024	BUY	$110.31 - $140.45 $614,426 - $782,306	5,570 Added 2.25%	253,510 $28.7 Million
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $685,320 - $840,600	-6,000 Reduced 2.36%	247,940 $34.4 Million

Q4 2023 Jan 08, 2024	BUY	$75.49 - $124.16 $309,509 - $509,056	4,100 Added 1.64%	253,940 $31.5 Million
Q3 2023 Oct 10, 2023	BUY	$86.06 - $137.93 $8.34 Million - $13.4 Million	96,940 Added 63.4%	249,840 $23.3 Million
Q2 2023 Jul 07, 2023	BUY	$112.47 - $130.98 $17.2 Million - $20 Million	152,900 New	152,900 $19.6 Million

1,082

377M

6.76M

7.24M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Covea Finance, based on Form 13F filings with the SEC.

Stay updated on Covea Finance with notifications on news.